Methylene Blue promotes cortical neurogenesis and ameliorates behavioral deficit after photothrombotic stroke in rats. (12th November 2016)

• Record Type: Journal Article
• Authors: Ahmed, Mohammad Ejaz; Tucker, Donovan; Dong, Yan; Lu, Yujiao; Zhao, Ningjun; Wang, Ruimin; Zhang, Quanguang
• Is Part Of: Neuroscience. Volume 336(2016)
• Page Start: 39
• Page End: 48
• Publication Date: 2016-11-12
• Subjects: BrdU 5-bromodeoxyuridine -- DTT dithiotheitol -- ip intraperitoneally -- MB Methylene Blue -- PBS phosphate-buffered saline -- PFA paraformaldehyde -- PT photothrombotic; Methylene Blue -- neurogenesis -- inflammation -- mitochondria -- photothrombotic stroke; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2016.08.036
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: Methylene Blue ameliorates sensorimotor deficits after photothrombotic (PT) stroke. Methylene Blue stimulates neurogenesis in the peri-infarct region after PT stroke. Methylene Blue reduces neuroinflammation in the peri-infarct region after PT stroke. Methylene Blue treatment promotes mitochondrial activity and ATP production. Methylene Blue treatment reduces infarct volume after PT stroke. Abstract: Ischemic stroke in rodents stimulates neurogenesis in the adult brain and the proliferation of newborn neurons that migrate into the penumbra zone. The present study investigated the effect of Methylene Blue (MB) on neurogenesis and functional recovery in a photothrombotic (PT) model of ischemic stroke in rats. PT stroke model was induced by photo-activation of Rose Bengal dye in cerebral blood flow by cold fiber light. Rats received intraperitoneal injection of either MB (0.5 mg/kg/day) from day 1 to day 5 after stroke or an equal volume of saline solution as a control. Cell proliferative marker 5-bromodeoxyuridine (BrdU) was injected twice daily (50 mg/kg) from day 2 to day 8 and animals were sacrificed on day 12 after PT induction. We report that MB significantly enhanced cell proliferation and neurogenesis, as evidenced by the increased co-localizations of BrdU/NeuN, BrdU/DCX, BrdU/MAP2 and BrdU/Ki67 in the peri-infarct zone compared with vehicle controls. MB thus effectively limited infarct volume and improved neurological deficits compared to PT control animals. The effects of MB were accompanied with an attenuated level of reactive gliosis and release of pro-inflammatory cytokines, as well as elevated levels of cytochrome c oxidase activity and ATP production in peri-infarct regions. Our study provides important information that MB has the ability to promote neurogenesis and enhance the newborn-neurons' survival in ischemic brain repair by inhibiting microenvironmental inflammation and increasing mitochondrial function.